Jeffrey R Wozniak

Prof. Jeffrey R Wozniak

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The Lancet Neurology
Verified
Journal Article
Closed access
JWJeffrey R Wozniak
Jeffrey R Wozniak
EREdward P Riley
Edward P Riley
MCMichael Charness
Michael Charness

1 June 2007 in Archives of Clinical Neuropsychology
Verified
Journal Article
Closed access
JWJeffrey R Wozniak
Jeffrey R Wozniak
LKL Krach
L Krach
EWE Ward
E Ward
BMB Mueller
B Mueller
RMR Muetzel
R Muetzel
KLK Lim
K Lim
This study examined the sensitivity of diffusion tensor imaging (DTI) to microstructural white matter (WM) damage in mild and moderate pediatric traumatic brain injury (TBI). Fourteen children with TBI and 14 controls ages 10-18 had DTI scans and neurocognitive evaluations at 6-12 months post-injury. Groups did not differ in intelligence, but children with TBI showed slower processing speed, working memory and executive deficits, and greater behavioral dysregulation. The TBI group had lower fractional anisotropy (FA) in three WM regions: inferior frontal, superior frontal, and supracallosal. There were no group differences in corpus callosum. FA in the frontal and supracallosal regions was correlated with executive functioning. Supracallosal FA was also correlated with motor speed. Behavior ratings showed correlations with supracallosal FA. Parent-reported executive deficits were inversely correlated with FA. Results suggest that DTI measures are sensitive to long-term WM changes and associated with cognitive functioning following pediatric TBI.


1 January 2008 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
KLKelvin O. Lim
Kelvin O. Lim
JWJeffrey R Wozniak
Jeffrey R Wozniak
BMBryon A. Mueller
Bryon A. Mueller
DFDaniel T. Franc
Daniel T. Franc
SSSheila M. Specker
Sheila M. Specker
JRJohn P. Rotrosen
John P. Rotrosen

1 November 2015 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
JWJeffrey R Wozniak
Jeffrey R Wozniak
AFAnita J Fuglestad
Anita J Fuglestad
JEJudith K Eckerle
Judith K Eckerle
BFBirgit A Fink
Birgit A Fink
HHHeather L Hoecker
Heather L Hoecker
MGMichael K Georgieff
Michael K Georgieff
Background: Fetal alcohol spectrum disorders (FASDs) are conditions characterized by physical anomalies, neurodevelopmental abnormalities, and neuroco

12 March 2020 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
JWJeffrey R Wozniak
Jeffrey R Wozniak
BFBirgit A. Fink
Birgit A. Fink
AFAnita J. Fuglestad
Anita J. Fuglestad
JEJudith K. Eckerle
Judith K. Eckerle
CBChristopher J. Boys
Christopher J. Boys
MGMichael K. Georgieff
Michael K. Georgieff
Background: Despite the high prevalence of fetal alcohol spectrum disorder (FASD), there are few interventions targeting its core neurocognitive and behavioral deficits. FASD is often conceptualized as static and permanent, but interventions that capitalize on brain plasticity and critical developmental windows are emerging. We present a long-term follow-up study evaluating the neurodevelopmental effects of choline supplementation in children with FASD 4 years after an initial efficacy trial. Methods: The initial study was a randomized, double-blind, placebo-controlled trial of choline vs. placebo in 2–5-year-olds with FASD. Participants include 31 children (16 placebo; 15 choline) seen 4 years after trial completion. The mean age at follow-up was 8.6 years. Diagnoses were 12.9% fetal alcohol syndrome (FAS), 41.9% partial FAS, and 45.1% alcohol-related neurodevelopmental disorder. The follow-up included measures of intelligence, memory, executive functioning, and behavior. Results: Children who received choline had higher non-verbal intelligence, higher visual-spatial skill, higher working memory ability, better verbal memory, and fewer behavioral symptoms of attention deficit hyperactivity disorder than the placebo group. No differences were seen for verbal intelligence, visual memory, or other executive functions. Conclusions: These data support choline as a potential neurodevelopmental intervention for FASD and highlight the need for long-term follow-up to capture treatment effects on neurodevelopmental trajectories. Trial registration: ClinicalTrials.Gov #NCT01149538; Registered: June 23, 2010; first enrollment July 2, 2010